International Stem Cell (OTCMKTS:ISCO) Stock Crosses Above 200-Day Moving Average – Here’s Why

International Stem Cell Corp. (OTCMKTS:ISCO)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.17 and traded as high as $0.26. International Stem Cell shares last traded at $0.26, with a volume of 800 shares changing hands.

International Stem Cell Trading Down 9.7%

The business’s fifty day moving average price is $0.19 and its 200-day moving average price is $0.17. The company has a market capitalization of $2.08 million, a P/E ratio of -4.33 and a beta of -0.01.

International Stem Cell (OTCMKTS:ISCO) last released its earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) EPS for the quarter. The company had revenue of $2.32 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.